Easton Pharmaceuticals, Inc. (EAPH)

[Bayeah]

If you want to look back, no question the prior management was sloppy and had poor execution. It's a changed company "clearly" with what looks like approx. $20 million in revenue. When enough people realize these successes the stock will jump big time. If they in fact landed a deal with Bayer - then it demonstrates that they can actively compete and operate with the best of them. If they can do that - then I think they will do many other deals that build on revenue.